Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
62.932,39
-1,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Cytek Biosciences Inc (CTKB) Cytek Biosciences Inc (CTKB) Notizie

Cytek Biosciences Inc

CTKB
5,76
0,13 (2,31%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/3/202413:00GLOBECytek® Biosciences Names William McCombe Chief Financial..
09/3/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:30GLOBECytek® Biosciences Opens New Facility to Address Increasing..
01/3/202412:06EDGAR2Form 8-K - Current report
28/2/202423:05GLOBECytek Biosciences Reports Fourth Quarter and Full Year 2023..
27/2/202412:06EDGAR2Form 8-K - Current report
22/2/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:10GLOBECytek Biosciences to Participate in Upcoming Investor..
07/2/202422:05GLOBECytek Biosciences to Report Fourth Quarter and Full Year..
17/1/202423:30GLOBECytek® Biosciences Signs Agreement with CRG and UPF to..
09/1/202412:05EDGAR2Form 8-K - Current report
08/1/202415:00GLOBECytek Biosciences Announces Preliminary Full Year 2023..
28/12/202322:05GLOBECytek Biosciences to present at the 42nd Annual J.P. Morgan..
27/12/202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:00GLOBECytek® Biosciences Introduces the Cytek Orion™ Reagent..
19/12/202322:28EDGAR2Form 144 - Report of proposed sale of securities
28/11/202313:00EDGAR2Form 8-K - Current report
28/11/202302:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202302:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:17EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202322:05GLOBECytek Biosciences to participate in the Piper Sandler 35th..
13/11/202322:02EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202312:06EDGAR2Form 8-K - Current report
09/11/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202315:00GLOBECytek® Aurora™ CS System Wins BioTech Breakthrough Award for..
07/11/202322:45EDGAR2Form 8-K - Current report
07/11/202322:05GLOBECytek Biosciences Reports Third Quarter 2023 Financial..
26/10/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202322:03EDGAR2Form 144 - Report of proposed sale of securities
24/10/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202322:05GLOBECytek Biosciences to Report Third Quarter 2023 Financial..
19/10/202322:02EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 5,69 Min: 5,59 Max: 5,76
Chiusura: 5,63

La tua Cronologia

NASDAQ
CTKB
Cytek Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network